Drugs / IFN-α
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04749368 | Apr 2021 → Jul 2023 | chronic hepatitis B virus infection | Brii Biosciences Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFN-α | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04749368 ↗ |
| Route | Intramuscular | “BRII-179 (VBI-2601) with IFN-α will be co-administered by intramuscular injection” NCT04749368 ↗ |